TFX · Teleflex Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $548.26M | - | $913.02M | $780.89M | $700.67M | - | $764.38M | $749.69M | $737.85M | - |
| Cost of Revenue | $240.84M | - | $461.38M | $349.80M | $311.23M | - | $334.20M | $333.23M | $321.71M | - |
| Gross Profit | $307.43M | - | $451.64M | $431.08M | $389.44M | - | $430.17M | $416.46M | $416.13M | - |
| R&D | $44.39M | - | $57.23M | $38.52M | $36.40M | - | $38.73M | $41.09M | $37.30M | - |
| SG&A | $226.01M | - | $281.76M | $215.08M | $222.71M | - | $247.26M | $250.63M | $242.83M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $53.74M | - | $68.64M | $68.13M | $66.04M | - | - | - | $15.93M | - |
| Operating Income | $20.18M | - | ($408.90M) | $155.31M | $125.57M | - | $149.31M | $116.88M | ($4.79M) | - |
| Interest Expense | $25.72M | - | $31.84M | $21.17M | $22.68M | - | $21.06M | $21.17M | $22.68M | - |
| Income Tax | $1.01M | - | ($29.70M) | $12.66M | $13.84M | - | $19.63M | $17.33M | ($41.55M) | - |
| Net Income | ($8.15M) | - | ($408.89M) | $122.58M | $95.00M | - | $111.00M | $80.04M | $15.29M | - |
| EPS - Basic | ($0.18) | - | ($9.24) | $2.77 | $2.08 | - | $2.38 | $1.70 | $0.32 | - |
| EPS - Diluted | ($0.18) | - | ($9.24) | $2.77 | $2.07 | - | $2.36 | $1.69 | $0.32 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $309.41M | $378.56M | $354.00M | $253.70M | $284.12M | $290.19M | $243.24M | $238.57M | $237.42M | $222.85M |
| Accounts Receivable | $365.53M | $345.58M | $592.65M | $513.81M | $464.52M | $459.50M | $470.26M | $448.90M | $448.53M | $443.47M |
| Inventory | $380.86M | $404.39M | $802.47M | $693.69M | $643.97M | $600.13M | $639.94M | $636.91M | $627.87M | $626.22M |
| Accounts Payable | $143.63M | $130.20M | $165.91M | $157.56M | $143.04M | $141.03M | $119.25M | $113.45M | $115.94M | $132.25M |
| Current Assets | $1.86B | $1.94B | $1.99B | $1.72B | $1.54B | $1.47B | $1.50B | $1.44B | $1.43B | $1.41B |
| Total Assets | $6.78B | $6.95B | $7.87B | $7.38B | $7.16B | $7.10B | $7.49B | $7.44B | $7.48B | $7.53B |
| Current Liabilities | $728.05M | $762.03M | $773.03M | $716.15M | $675.91M | $649.36M | $618.75M | $556.75M | $571.01M | $606.75M |
| Long-term Debt | $2.51B | $2.54B | $2.57B | $1.80B | $1.81B | $1.56B | $1.66B | $1.62B | $1.67B | $1.73B |
| Total Liabilities | $3.70B | $3.82B | $4.05B | $3.13B | $3.07B | $2.82B | $3.00B | $2.88B | $2.97B | $3.09B |
| Stockholders' Equity | $3.08B | $3.12B | $3.82B | $4.24B | $4.10B | $4.28B | $4.48B | $4.56B | $4.50B | $4.44B |
| Retained Earnings | - | $3.15B | - | - | - | $4.12B | - | - | - | $4.11B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $46.66M | - | - | - | $73.34M | - | - | - | $112.84M | - |
| Investing Cash Flow | ($74.78M) | - | - | - | ($28.79M) | - | - | - | ($24.81M) | - |
| Financing Cash Flow | ($44.98M) | - | - | - | ($59.52M) | - | - | - | ($71.45M) | - |
| CapEx | $18.79M | - | - | - | $30.01M | - | - | - | $38.43M | - |
| Free Cash Flow | $27.87M | - | - | - | $43.33M | - | - | - | $74.41M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 56.1% | - | 49.5% | 55.2% | 55.6% | - | 56.3% | 55.6% | 56.4% | - |
| Operating margin | 3.7% | - | -44.8% | 19.9% | 17.9% | - | 19.5% | 15.6% | -0.6% | - |
| EBITDA margin | 13.5% | - | -37.3% | 28.6% | 27.3% | - | - | - | 1.5% | - |
| Net margin | -1.5% | - | -44.8% | 15.7% | 13.6% | - | 14.5% | 10.7% | 2.1% | - |
| Free cash flow margin | 5.1% | - | - | - | 6.2% | - | - | - | 10.1% | - |
| FCF / Net income | -3.42 | - | - | - | 0.46 | - | - | - | 4.87 | - |
| R&D / Revenue | 8.1% | - | 6.3% | 4.9% | 5.2% | - | 5.1% | 5.5% | 5.1% | - |
| SG&A / Revenue | 41.2% | - | 30.9% | 27.5% | 31.8% | - | 32.3% | 33.4% | 32.9% | - |
| Effective tax rate | - | - | - | 9.4% | 12.7% | - | 15.0% | 17.8% | - | - |
| Return on assets | -0.1% | - | -5.2% | 1.7% | 1.3% | - | 1.5% | 1.1% | 0.2% | - |
| Return on equity | -0.3% | - | -10.7% | 2.9% | 2.3% | - | 2.5% | 1.8% | 0.3% | - |
| Return on invested capital | 0.3% | - | -5.1% | 2.3% | 1.9% | - | 2.1% | 1.6% | -0.1% | - |
| Liquidity | ||||||||||
| Current ratio | 2.55 | 2.54 | 2.57 | 2.41 | 2.28 | 2.27 | 2.42 | 2.58 | 2.51 | 2.32 |
| Quick ratio | 2.03 | 2.01 | 1.53 | 1.44 | 1.32 | 1.34 | 1.39 | 1.44 | 1.41 | 1.29 |
| Cash ratio | 0.42 | 0.50 | 0.46 | 0.35 | 0.42 | 0.45 | 0.39 | 0.43 | 0.42 | 0.37 |
| Leverage | ||||||||||
| Debt / Equity | 0.82 | 0.81 | 0.67 | 0.42 | 0.44 | 0.36 | 0.37 | 0.36 | 0.37 | 0.39 |
| Debt / Assets | 0.37 | 0.37 | 0.33 | 0.24 | 0.25 | 0.22 | 0.22 | 0.22 | 0.22 | 0.23 |
| Debt / EBITDA | 34.01 | - | - | 8.06 | 9.43 | - | - | - | 149.79 | - |
| Interest coverage | 0.8x | - | -12.8x | 7.3x | 5.5x | - | 7.1x | 5.5x | -0.2x | - |
| Equity multiplier | 2.20 | 2.22 | 2.06 | 1.74 | 1.75 | 1.66 | 1.67 | 1.63 | 1.66 | 1.70 |
| Liabilities / Assets | 0.55 | 0.55 | 0.51 | 0.42 | 0.43 | 0.40 | 0.40 | 0.39 | 0.40 | 0.41 |
| Efficiency | ||||||||||
| Asset turnover | 0.08 | - | 0.12 | 0.11 | 0.10 | - | 0.10 | 0.10 | 0.10 | - |
| Inventory turnover | 0.63 | - | 0.57 | 0.50 | 0.48 | - | 0.52 | 0.52 | 0.51 | - |
| Days sales outstanding | 243d | - | 237d | 240d | 242d | - | 225d | 219d | 222d | - |
| Days inventory outstanding | 577d | - | 635d | 724d | 755d | - | 699d | 698d | 712d | - |
| Days payable outstanding | 218d | - | 131d | 164d | 168d | - | 130d | 124d | 132d | - |
| Cash conversion cycle | 603d | - | 741d | 800d | 829d | - | 793d | 792d | 803d | - |
| Valuation | ||||||||||
| P / E | - | - | - | 43.1x | 66.6x | - | 104.6x | 124.5x | 706.8x | - |
| P / B | 1.7x | - | 1.4x | 1.2x | 1.5x | - | 2.6x | 2.2x | 2.4x | - |
| P / S | 9.7x | - | 5.8x | 6.8x | 9.0x | - | 15.2x | 13.3x | 14.5x | - |
| EV / EBITDA | 101.4x | - | - | 30.6x | 41.0x | - | - | - | 1091.1x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -21.8% | - | 19.4% | 4.2% | -5.0% | - | 2.4% | 0.9% | 3.8% | - |
| Revenue CAGR (3y) | -8.3% | - | 10.0% | 3.5% | 3.0% | - | 3.0% | 1.7% | 5.2% | - |
| Revenue CAGR (5y) | -2.9% | - | 7.8% | 6.6% | 2.1% | - | 3.3% | 2.8% | 3.8% | - |
| Gross profit growth (YoY) | -21.1% | - | 5.0% | 3.5% | -6.4% | - | 3.3% | 2.1% | 6.3% | - |
| Operating income growth (YoY) | -83.9% | - | - | 32.9% | - | - | -9.7% | -18.6% | - | - |
| Net income growth (YoY) | - | - | - | 53.2% | 521.4% | - | -19.1% | -28.1% | -80.1% | - |
| EPS growth (YoY) | - | - | - | 63.9% | 546.9% | - | -18.6% | -28.1% | -80.2% | - |
| EPS CAGR (3y) | - | - | - | 7.5% | 8.3% | - | -17.5% | -1.3% | -41.3% | - |
| EPS CAGR (5y) | - | - | - | 63.1% | -5.7% | - | -13.4% | -0.9% | -18.1% | - |
| FCF growth (YoY) | -35.7% | - | - | - | -41.8% | - | - | - | 19.0% | - |
| FCF CAGR (5y) | -21.2% | - | - | - | - | - | - | - | 15.2% | - |
| Book value growth (YoY) | -24.7% | -27.0% | -14.7% | -6.9% | -9.1% | -3.7% | 3.9% | 8.2% | 9.6% | 10.4% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$1.99B totalAmericas Segment$1.28B · 64.2%
EMEASegment$472.41M · 23.7%
Asia Segment$241.10M · 12.1%
Product / service
$1.99B totalVascular Access$917.73M · 46.1%
Interventional$647.79M · 32.5%
Surgical$418.15M · 21.0%
Other$9.04M · 0.5%
Geographic
$1.99B totalUS$1.18B · 59.3%
Europe$484.73M · 24.3%
Asia And Asia Pacific$218.03M · 10.9%
All Other$108.13M · 5.4%
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing TELEFLEX INC against the 5 most active filers in the same SIC group.
Dividends
$1.36/share trailing 12 months · 0.0% YoY
| Ex-date | Per share |
|---|---|
| May 22, 2026 | $0.3400 |
| Mar 6, 2026 | $0.3400 |
| Nov 14, 2025 | $0.3400 |
| Aug 15, 2025 | $0.3400 |
| May 20, 2025 | $0.3400 |
| Mar 7, 2025 | $0.3400 |
| Nov 15, 2024 | $0.3400 |
| Aug 15, 2024 | $0.3400 |
| May 14, 2024 | $0.3400 |
| Feb 29, 2024 | $0.3400 |
| Nov 14, 2023 | $0.3400 |
| Aug 14, 2023 | $0.3400 |
| May 12, 2023 | $0.3400 |
| Mar 2, 2023 | $0.3400 |
| Nov 14, 2022 | $0.3400 |
| Aug 12, 2022 | $0.3400 |
| May 13, 2022 | $0.3400 |
| Mar 4, 2022 | $0.3400 |
| Nov 12, 2021 | $0.3400 |
| Aug 13, 2021 | $0.3400 |
| May 13, 2021 | $0.3400 |
| Mar 4, 2021 | $0.3400 |
| Nov 12, 2020 | $0.3400 |
| Aug 13, 2020 | $0.3400 |